Could a natural compound calm COVID-19's deadly inflammation?
NCT ID NCT04476953
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 26 times
Summary
This study tests whether fisetin, a natural senolytic drug, can prevent COVID-19 from getting worse by calming the body's excessive inflammatory response. About 80 hospitalized adults aged 60+ (or 18-59 with certain health conditions) will receive fisetin or a placebo. The goal is to see if fisetin improves oxygen levels and reduces serious complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.